Prevalence of life-threating disorders such as hemophilia and increase in adoption of blood plasma derivatives products drive the growth of the global blood plasma derivatives market. In addition, rise in awareness regarding the blood and plasma donation supplements the growth. The immunoglobin segment accounted for nearly half of the total revenue in 2017 and will maintain its dominance by 2023.

Portland, OR, June 17, 2019 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global blood plasma derivatives market held $25.98 billion in 2017 and is estimated to garner $44.33 billion by 2023, growing at a CAGR of 9.3% from 2017 to 2023. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario.

High demand for blood plasma derivatives owing to increase in life-threating diseases and growth in the geriatric population drives the market. However, risks associated with plasma derivatives along with high cost of blood plasma derivatives-based therapy restrict the market growth. On the contrary, high adaptation of blood plasma derivatives would present opportunities in the global blood plasma derivatives market.

Request Report Sample at: https://www.alliedmarketresearch.com/request-sample/656

Immunoglobulin segment to maintain its dominance by 2023

The Immunoglobulin segment accounted for nearly half of the total revenue in 2017 and will maintain its dominance by 2023. This segment is expected to register the highest growth rate with a CAGR of 10% during the forecast period. The report also explores other types including Albumin, Factor VIII, Factor IX, Hyperimmune globulins, and others.

North America to maintain lead position by 2023

The market across North America accounted for more than two-fifths of the market in terms of revenue in 2017. However, the market across Asia-Pacific is expected to grow at the highest CAGR of 10.2% during the forecast period. The report also explores other regions including Europe and LAMEA.

Immunodeficiency diseases segment to lead throughout the forecast period   

The immunodeficiency diseases segment accounted for nearly one-third of the total revenue in 2017 and will maintain its dominance by 2023. This segment is projected to register the highest growth rate with a CAGR of 10.3% during the study period. 

Hospitals segment to maintain its dominance by 2023

The hospitals segment accounted for more than two-thirds of the market in terms of revenue in 2017. However, the clinics segment is expected to grow at the highest CAGR of 10.1% during the forecast period.

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/656

Leading market players

The key market players explored in the research include Green Cross Corporation, SK Plasma Co. Ltd., Octapharma AG, Grifols, S.A., Biotest AG, Fusion Health Care Pvt. Ltd., Shire Plc., Baxter International Inc., LFB S.A., and CSL Limited.

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada): 
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com 
Web: https://www.alliedmarketresearch.com